Is cancer incidence modified by SGLT2 inhibitors?
One of the most important achievements of diabetology in the second decade of the 21st century is undoubtedly the introduction of sodium-glucose cotransporter (SGLT2) inhibitors into clinical practice as a new class of glucose-lowering agents for type 2 diabetes. In addition to the glucosuria induce...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Language: | EN RU |
| Published: |
Endocrinology Research Centre
2019
|
| Subjects: | |
| Online Access: | https://doaj.org/article/e2a9284c7a5f48c585b794a470d53010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|